December 2021 • PharmaTimes Magazine • 4-5
M&A returns – but in a new form
PharmaTimes talks to Janssen’s Vice President, Oncology, EMEA and Commercial Strategy Lead
38.
Appointments
13.
Thought Leadership
COUCH CEO Ash Rishi addresses implicit bias in clinical trials
29.
Thought Leadership
Advanz Pharma’s CEO Graeme Duncan reflects on 2021